Monsanto Company (NYSE:MON)’s share price gapped up before the market opened on Monday . The stock had previously closed at $121.94, but opened at $122.30. Monsanto shares last traded at $122.31, with a volume of 1,175,181 shares changing hands.

MON has been the subject of a number of analyst reports. UBS AG lowered Monsanto from a “positive” rating to a “neutral” rating in a research report on Tuesday, June 27th. Susquehanna Bancshares Inc restated a “neutral” rating and issued a $128.00 price target (up from $125.00) on shares of Monsanto in a research report on Tuesday, June 27th. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target for the company in a research report on Tuesday, June 27th. Royal Bank Of Canada restated a “sector perform” rating and issued a $128.00 price target (up from $120.00) on shares of Monsanto in a research report on Thursday, June 29th. Finally, Barclays PLC upped their price target on Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a research report on Thursday, June 29th. Eleven equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $124.61.

The company has a market cap of $53.68 billion, a price-to-earnings ratio of 24.00 and a beta of 1.07. The stock’s 50 day moving average is $118.79 and its 200 day moving average is $117.33.

Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The firm had revenue of $2.69 billion during the quarter, compared to analysts’ expectations of $2.51 billion. During the same period in the prior year, the company earned $0.07 EPS. The firm’s revenue was up 4.8% on a year-over-year basis. On average, equities analysts anticipate that Monsanto Company will post $5.70 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be given a dividend of $0.54 per share. The ex-dividend date is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.77%. Monsanto’s dividend payout ratio (DPR) is 42.27%.

In related news, COO Brett D. Begemann sold 22,640 shares of the company’s stock in a transaction on Monday, September 25th. The shares were sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the completion of the sale, the chief operating officer now directly owns 85,439 shares of the company’s stock, valued at approximately $10,255,243.17. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Duraiswami Narain sold 2,860 shares of the company’s stock in a transaction on Monday, September 25th. The stock was sold at an average price of $120.00, for a total transaction of $343,200.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 37,026 shares of company stock valued at $4,440,341. 0.79% of the stock is owned by corporate insiders.

A number of institutional investors have recently made changes to their positions in the stock. Yorkville Capital Management LLC boosted its position in Monsanto by 2.7% during the 2nd quarter. Yorkville Capital Management LLC now owns 18,800 shares of the basic materials company’s stock worth $2,225,000 after purchasing an additional 500 shares during the period. Paulson & CO. Inc. boosted its position in Monsanto by 348.5% during the 2nd quarter. Paulson & CO. Inc. now owns 159,200 shares of the basic materials company’s stock worth $18,843,000 after purchasing an additional 123,700 shares during the period. Intl Fcstone Inc. purchased a new stake in Monsanto during the 2nd quarter worth $794,000. Paradigm Financial Advisors LLC boosted its position in Monsanto by 44.7% during the 2nd quarter. Paradigm Financial Advisors LLC now owns 17,316 shares of the basic materials company’s stock worth $2,050,000 after purchasing an additional 5,351 shares during the period. Finally, Ashburton Jersey Ltd boosted its position in Monsanto by 20.4% during the 2nd quarter. Ashburton Jersey Ltd now owns 21,642 shares of the basic materials company’s stock worth $2,562,000 after purchasing an additional 3,660 shares during the period. 74.77% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This piece was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/10/18/monsanto-company-mon-shares-gap-up-to-122-30.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.